Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Thursday, July 7, 2022, 7:14
- Business
- Add a comment
HAMILTON, ON and BOSTON, July 7, 2022 /PRNewswire/ — Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced that the compensation committee of the Company’s Board of…
About the Author
adminasapcorp has written 41555 stories on this site.